Windlas Biotech Limited IPO (Windlas Biotech IPO)

Windlas Biotech IPO
New Windlas Biotech IPO | Upcoming Windlas Biotech IPO | New Windlas Biotech IPO 2021 | Latest Windlas IPO | Windlas IPO 2021

Compiled in 2001, Windlas Biotech Ltd is one of the leading companies in the development and manufacturing contract (CDMO) in India. The company offers a wide range of CDMO services from product discovery to product development, licensing, and commercialization of standard products including complex generic.

It also sells its branded products in the genics market and OTC markets. At present, the company is focused on introducing standard medical products to chronic treatment related to lifestyle-related disorders. The business operates in 3 vertical; 1. CDMO products and services, 2. Over-the-counter and over-the-counter (OTC) (nutraceutical and health supplement products) products, and 3. Export.

Leading pharma companies namely Pfizer Ltd, Sanofi India Ltd, Cadila Healthcare Ltd, Emcure Pharmaceuticals Ltd, Eris Lifesciences Ltd, Intas Pharmaceuticals Ltd, and Systopic Laboratories Private Limited are other customers of Windlas Biotech market. Its production facilities are located at Dehradun with an installed capacity of 7,063.83 million tablets / tablets, bag / bag, and 61.08 million liquid bottles.

Windlas Biotech IPO

Competitive Strengths

  • Leading market player in the domestic pharmaceutical formulation CDMO segment.
  • Strong focus on the chronic therapeutic category.
  • state-of-the-art manufacturing facilities in Dehradun, Uttarakhand.
  • Professional and experienced Promoters and a senior management team.
  • An innovative product portfolio of complex generic products.
  • Robust financial performance track record.

Company Promoters

Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and AKW WBL Family Pvt Trust are the company promoters.

Company Financials

ParticularsFor the year/period ended (₹ in million)
31-Dec-2031-Mar-2031-Mar-1931-Mar-18
Total Assets3,158.833,384.882,981.802,898.87
Total Revenue3,230.943,313.393,115.253,565.76
Profit After Tax96.74162.13638.22111.98

Objects Of The Issue

  • To purchase equipment required for capacity expansion of our existing facility at Dehradun Plant IV.
  • To finance incremental working capital requirements of the company.
  • Repayment/prepayment of company’s borrowings.
  • General corporate purposes.
Windlas Biotech IPO
Object Of The Issue

Windlas Biotech IPO – Details

IPO Opening DateAug 04, 2021
IPO Closing DateAug 06, 2021
Issue TypeBook Built Issue IPO
Issue Size401.53 Crore
Face Value₹5 per equity share
IPO Price[448] To [460] Per Equity Share
Market Lot30 Shares
Min Order Quantity30 Shares
Listing AtBSE NSE
Total Share Issue87,29,023 Equity Share
RegisterLinkInTime India Private Limited

Windlas Biotech IPO – Timetable

IPO Open DateAug 04, 2021
IPO Close DateAug 06, 2021
Basis of Allotment DateAug 11, 2021
Initiation of RefundsAug 12, 2021
Credit of Shares to Demat AccountAug 13, 2021
IPO Listing DateAug 16, 2021

Windlas Biotech IPO Lots Size & Price

ApplicationLotsSharesAmount ( Cut-Off)
Minimum13013,800
Maximum133901,79,400

Company Contact Information

Windlas Biotech Limited
40/1, Mohabewala Industrial Area,
Dehradun, 248110

Phone: +91 135 6608000
Email: grievance@windlasbiotech.com
Websitehttp://www.windlasbiotech.com/

Windlas Biotech IPO FAQs

What is Windlas Biotech IPO?

Windlas Biotech IPO is a main-board IPO of [.] equity shares of the face value of ₹5 aggregating up to ₹[.] Crores. The issue is priced at [.] to [.] per equity share. The minimum order quantity is .

The IPO opens on Aug 4, 2021, and closes on Aug 6, 2021.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
When Windlas Biotech IPO will open?

The Windlas Biotech IPO opens on Aug 4, 2021 and closes on Aug 6, 2021.
What is the lot size of Windlas Biotech IPO?

Windlas Biotech IPO lot size and the minimum order quantity is not available at this time. Please check again later.
How to apply for Windlas Biotech IPO?

You can apply in Windlas Biotech IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services.
When is Windlas Biotech IPO listing date?

The Windlas Biotech IPO listing date is announced. The date of Windlas Biotech IPO listing is Aug 16, 2021.

LIST OF UPCOMING IPOs